Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Natalizumab (Tysabri) for Crohn’s Disease

doi: 10.1097/01.AOG.0000326889.48420.4a
Departments: Medical Letter

The following articles from The Medical Letter have been selected on the basis of their importance to obstetrician- gynecologists. For information on how to subscribe to The Medical Letter, go to

The Medical Letter, Volume 50, Issue 1285, May 5, 2008

© 2008 by The American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.